本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Pyxis Oncology, Inc.

1.10
-0.1000-8.33%
盘后1.100.00000.00%16:31 EDT
成交量:50.40万
成交额:59.15万
市值:6,814.24万
市盈率:-0.70
高:1.24
开:1.22
低:1.10
收:1.20
数据加载中...
2023/05/11

重要事件披露

8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/10

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/04

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report
2023/03/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/22

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/22

重要事件披露

8-K - Current report
2023/03/22

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/16

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/01

重要事件披露

8-K - Current report
2022/11/10

SEC问询函

CORRESP [Cover] - Correspondence
2022/11/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/01

重要事件披露

8-K - Current report